2BB score and signals
Travere Therapeutics, Inc.’s current 2BB score is 46 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 68 | High |
| Momentum | 57 | Stable |
| Financial strength | 49 | Normal |
| Quality | 98 | Very Strong |
| Risk | 36 | Low |
Company facts
| Founded | 2011 |
| Employees | 497 |
| 52-week range | $22.59 – $68.73 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-10-22 | — | 0.0622 | — | $199.59M |
| 2026-08-04 | — | -0.1415 | — | $162.78M |
| 2026-05-04 | -0.4 | -0.2709 | $127.20M | $139.01M |
| 2026-02-19 | 0.03 | -0.1204 | $129.69M | $145.08M |
Related companies
